Intragastric balloons market worth US$198.56 million by 2021

Intragastric balloons are the saline-filled silicone balloons placed in the stomach for a span of months and limits intake of food by giving the feeling of satiety. These balloons permit patients to sense fullness, controls hunger, delays gastric emptying by altering gut hormones and peptides thus reducing food intake ultimately.

Today, intragastric balloons can be used as treatment for obesity as a pre-emptive therapy, a metabolic therapy, or a primary therapy. Endoscopic procedures under mild sedation are used to place one or more intragastric balloons in the stomach in an outpatient setting. These balloons not only help in weight loss but also helps in recovering the metabolic disorders. The intragastric balloons are widely used because of its advantages of easy implantation, cost effectiveness and less risk. There are various advantages offered by intragastric balloons such as improved metabolism, alterations in gastrointestinal hormones, low price, and short hospital stay.

The worldwide intragastric balloons market is expected to reach approx. US$198.56 million by 2021, growing at a CAGR of 7.01% during the forecast period 2015-2021.

Factors such as presence of a large obese population, change in lifestyle, need to reduce hospital stay, short recovery time, and availability of low-priced intragastric balloons are driving the growth of the global intragastric balloons market. Also, growing opportunities in the obesity market in the US are likely to serve as high growth revenue pockets for players operating in the market. In 2015, the US spent US$10,000 per person on healthcare annually; this figure is almost two-and a-half times that of countries in the Organization for Economic Cooperation and Development (OECD), and 50% higher than the next-highest spending countries, namely, Switzerland and Norway. A large portion of the US healthcare expenditure is spent on programs related to chronic diseases such as obesity. The growing adoption of intragastric balloons is expected to drive in the US to manage obesity.

However, limitations and adverse events of intragastric balloons are likely to limit the adoption of this technology. In terms of geography, EMEA accounted for a major share of the market in 2015. This can be attributed to increased consumption of fast food in these regions, reduced physical activities, and Europe being the old market to use intragastric ballooning technique.

Apollo Endosurgery, ReShape Medical, Helioscopie, Allurion Technologies, Obalon Therapeutics are among the leading players in the market. Fengh Medical, MEDSIL, Phagia Technologies, Silimed, Endalis, Tulip Medical Products, LIFE PARTNERS EUROPE, BARAnova Therapeutics, Districlass Medical, and Shandong Institute of Medical Instruments are other players in the market.

For more information, view the report abstract
http://www.beigemarketintelligence.com/reports/research-report-healthcare-market/intragastric-balloons-market/

About Beige Market Intelligence

Beige Market Intelligence is a provider of competitive business intelligence, working across various industry verticals. Our expertise and knowledge ensures that the market analysis Beige provides is comprehensive, detailed and complete. The analysis helps our client organizations become aware and to make educated decisions, as far as investing or devising a marketing strategy is concerned. The actionable insights delivered through our market research provide a comprehensive market analysis for every level of market segmentation in an industry.
Our team of experts ensure the analysis you receive is not just analyzed and presented, but can also be customized based on the client’s requirement. Our deliverables guarantee our current global client base do not look beyond Beige when it comes to competitive intelligence.
Beige has an employee base present across the globe. Our analysts come with numerous years of industry experience, which ensures we not only understand our clients but deliver high quality reports as well.

Beige Market Intelligence
Chinnapannahalli Main Road, Bangalore- 560037

Mail: contactus@beigemarketintelligence.com
US: +1 347 903 9949
UK: +44 20 323 99499
APAC: +91 99 012 75473

This release was published on openPR.